Keyphrases
Atrial Fibrillation
100%
Beta-blockers
30%
Persistent Atrial Fibrillation
29%
Platelets
26%
Ablation
19%
COVID-19
19%
Early Rhythm Control
19%
Rhythm Control
19%
C-type Lectin
19%
Receptor 2
19%
Fibroblast Growth Factor 23 (FGF23)
19%
Meta-analysis
19%
Atrial Fibrillation Ablation
18%
Heart Failure
18%
Quality of Life
16%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
15%
Cardiovascular Disease
15%
Left Atrial
14%
Left Ventricular Ejection Fraction
14%
Sinus Rhythm
14%
Randomized Controlled Trial
14%
Atrial Fibrillation Recurrence
14%
Patients with Heart Failure
14%
Natriuretic Peptides
13%
Cardiovascular Mortality
13%
Heart Failure Patients
11%
Early Therapy
11%
Thrombosis
10%
Catheter Ablation
10%
Heart Failure Hospitalization
10%
Older Adults
10%
Estimated Glomerular Filtration Rate
10%
High-throughput Platform
9%
Analytic Assessment
9%
Inflammatory Macrophages
9%
Immunoglobulin G
9%
Umbrella Review
9%
Medication Adherence
9%
Model Performance
9%
Gene-deficient Mice
9%
High-resolution
9%
Klotho
9%
Immune Thrombocytopenia
9%
Atrial Cardiomyocytes
9%
Cardiac Electrophysiology
9%
Patient Cohort
9%
PITX2
9%
Blood Filling
9%
Metaanalysis
9%
Functional Status
9%
C-type Lectin-like Receptor 2
9%
Platelet Factor 4
9%
Prolonged ECG Monitoring
9%
Risk of Bias
9%
Lymphatics
9%
Validation Studies
9%
Imaging Assessment
9%
Patient-centered
9%
Clinical Potential
9%
Risk Score
9%
Heart Disease Diagnosis
9%
Peritonitis
9%
Patient Association
9%
All-comers
9%
Vaccine Response
9%
Concomitant Conditions
9%
Mouse Model
9%
BMP10
9%
Right Ventricular Function
9%
Galectin-9 (Gal-9)
9%
Glycoprotein VI
9%
Treatment Patterns
9%
Uremic Cardiomyopathy
9%
Noninvasive Cardiac Imaging
9%
Holter
9%
Systematic Meta-analysis
9%
Clinical Model
9%
Machine Learning
9%
Anticoagulant Therapy
9%
G-levels
9%
Prognostic Model
9%
Optical Mapping
9%
Cluster Analysis
9%
Renal Impairment
9%
Mobile Application
9%
Assessment of Quality of Life
9%
Fully Digital
9%
Smartphone
9%
Atrial Arrhythmia
9%
Arrhythmogenic Right Ventricular Cardiomyopathy
9%
Tertiary Level
9%
Inherited Cardiac Conditions
9%
All-cause Mortality
9%
Podoplanin
9%
Atrial Tachycardia
8%
Echocardiography
8%
Usual Care
8%
Antiarrhythmic Drugs
8%
Confidence Interval
8%
C-statistic
8%
Comorbidity
7%
Symptomatic Patients
7%
Anti-platelet Factor 4 Antibodies
7%
Chronic Kidney Disease
6%
Action Potential
6%
Potential Transient
6%
Calcium Transient
6%
Odds Ratio
6%
Oral Anticoagulation
6%
Non-definite
6%
Clinical Benefit
6%
High-sensitivity Cardiac Troponin
5%
Ethnic Minorities
5%
Global Longitudinal Strain
5%
Patient Serum
5%
Clinical Outcomes
5%
Heart Rate
5%
Medicine and Dentistry
Atrial Fibrillation
75%
Congestive Heart Failure
34%
Quality of Life
19%
COVID-19
19%
Cardiovascular System
18%
Heart Left Ventricle Ejection Fraction
15%
Amino Terminal Sequence
14%
Brain Natriuretic Peptide
14%
Natriuretic Factor
13%
Fibroblast Growth Factor 23
13%
Systematic Review
12%
Permanent Atrial Fibrillation
11%
Electrocardiography Monitoring
11%
Myocardial Disease
10%
Sinus Rhythm
10%
Functional Status
9%
Biological Marker
9%
Anticoagulant Therapy
9%
Case Finding
9%
Cluster Analysis
9%
Rhythm
9%
Fibroblast
9%
Medication Compliance
9%
Cardiac Imaging
9%
Cardiovascular Disease
9%
Heart Right Ventricle Function
9%
Cardiac Electrophysiology
9%
Meta-Analysis
9%
Heart Atrium Arrhythmia
9%
Odds Ratio
9%
Arrhythmogenic Right Ventricular Dysplasia
9%
Randomized Controlled Trial
8%
Echocardiography
8%
All Cause Mortality
8%
Supraventricular Tachycardia
8%
Comorbidity
7%
Electrocardiogram
7%
Chronic Kidney Disease
7%
Atrial Fibrillation Ablation
6%
Isotopes of Calcium
6%
Action Potential
6%
Antiarrhythmic Agent
6%
Cardiac Troponin
5%
Systolic Function
5%
Reproducibility
5%
Anticoagulation
5%